Markets and Investing
February 25, 2020
One of the biggest potential impacts is to the supply chain, says John Ransom, managing director of healthcare research. “We source a lot of [active pharmaceutical ingredients] from India and China.”
Recorded February 25, 2020
Other posts you might like
ButlerFinancial
What are you waiting for?
read more
Markets & Investing May 30, 2023 Nick Goetze discusses fixed income market conditions and offers insight...
ButlerFinancial
The resilience of the U.S. economy: It’s all about employment, and the consumer
read more
Economy & Policy May 26, 2023 Chief Economist Eugenio J. Alemán discusses current economic...
ButlerFinancial
What will the Fed’s updated dot plots signal to the market?
read more
Markets & Investing May 26, 2023 Review the latest Weekly Headings by CIO Larry Adam. Key...
